Sunday, September 11, 2016


We Recently Purchased The Following:

Gilead Science, Inc (GILD)
Purchased 8 shares of GILD on 9/9/2016 at $78.53
Total Spent: $628.24; added $15.04 in forward dividends.

Our recent purchase of Gilead Science, Inc (GILD) is just the 3rd stock purchase made in our family's dividend stocks portfolio since February. We also bought Apple Inc (AAPL) and Flower Foods Inc (FLO), on June 24, 2016 and September 9, 2016, respectively. We hope the market continues to decline (as it did on Friday) so that we can continue grabbing a few more value buys! Not sure about you, but whether it is a stock or a consumer good, I love it when I can grab a good deal!  

Here are a few reasons why we believe GILD is a good buy: 1) GILD is trading at a 31.5% discount from its 52-week high; 2) Although the dividend is only 2.41%, their payout ratio is a low 16.4% which should allow GILD to continue to raise dividends for years to come; 3) GILD is a very large company with a market cap at 103.0 Billion.

Company Description
From Google Finance:
Gilead Sciences, Inc. is a research-based biopharmaceutical company. The Company focuses on the discovery, development and commercialization of medicines in areas of unmet medical need. The Company's principal areas of focus include human immunodeficiency virus (HIV), liver diseases, such as chronic hepatitis C virus infection and chronic hepatitis B virus infection, cardiovascular, hematology/oncology and inflammation/respiratory. Its HIV products include Genvoya, Stribild, Complera/Eviplera, Atripla, Truvada, Viread, Emtriva, Tybost and Vitekta. The Company's liver diseases products include Harvoni, Sovaldi, Viread and Hepsera. The Company's cardiovascular products include Letairis, Ranexa and Lexiscan/Rapiscan. Its oncology product is Zydelig. Its respiratory products include Cayston and Tamiflu. Its other products include AmBisome and Macugen. The Company's Nimbus Apollo program is a Phase II ready clinical program for NDI-010976 and related metabolic and liver diseases.

With our recent purchase of Gilead Science, Inc (GILD), the estimated forward dividends for our family's dividend stocks portfolio grew another $15.04, putting our yearly dividends at approximately $3,289/year (excluding our Edwards Jones account) and $3,674/year (including our Edward Jones account).  

Since did not previously own Gilead Science Inc, the recent buy of GILD added yet another dividend paying company to our family's dividend stocks portfolios (WF and EJ Accounts). The total stocks held in our family's dividend stock portfolio is now 56 different dividend paying stocks/ETFs and also 5 companies that either don't pay a dividend our has currently suspended their dividends.

Our family's dividend stocks portfolio may be found
by clicking on the link below:

We also maintain an extensive list of stock analysis
that can be access through the link below:

We also just started a list of Recent Buys by other bloggers
that can be access through the link below:


Gilead Science, Inc (GILD)
P/E: 6.88
Payout Ratio: 16.4%
Dividend Yield:2.41%

consecutive years of dividend increases
Last Ex-dividend date: 6/14/2016
Next Ex-dividend date: approx. 9/14/2016
Have paid a dividend since: 2015 (1 year)
Pays a dividend 4 times a year
Market Cap: 103.0 Billion
52-week high: $113.31
52-week low: $76.67

Purchased Price: $78.53

What are your thoughts on of recent purchase?

What are you buying?


  1. I think you bought at a good time. GILD is going to be around for a long time and they have a Low payout ratio that will probably grow.

    Good buy IMO

    1. Thanks Divi Cents. Love the market cap and the low payout ratio. You are right on and nailed the main reasons why we decided to buy. :)

      We plan to hang on to GILD well into retirement and looking forward to future dividend growth! AFFJ

  2. I like GILD! Glad you're a fellow shareholder, now -- congratulations.

    1. Although GILD does not have an extensive dividend history, we love their super low P/E and payout ratio and feel that at current prices, we enjoy both stock price gains as well as future dividend raises.


  3. I've been watching it for awhile. Good call!

    1. Thanks Passive Income dude, we are happy with the purchase and can see ourselves hanging one to GILD for years to come.

      Regards, AFFJ

  4. So we have company,i did buy GILD few weeks but the price seems to come down.

    1. Great to hear we are fellow shareholders in GILD. Even though you may have bought at a higher price, GILD is as such a nice discount that as a long term investor, we both should still see nice gains.

      Cheers to future growth and gains for both of us. AFFJ

  5. I'm very long on GILD. I own 100 shares and I've been selling puts the past few months hoping to get 100 more shares at a discount. If it drops a few more dollars, I'm going to buy 100 more shares anyway. Nice buy AFFJ.